Delivering on the promise of bone morphogenetic proteins.
The advent of bone growth factors has been widely anticipated since their successful production using recombinant DNA technology. Bone morphogenetic proteins (BMPs) are an important class of bone growth factors and will be the focus of this article. In the near future these therapeutics might revolutionize how clinicians treat such diverse orthopedic applications as the healing of broken bones, increasing bone density lost through aging, and strengthening the spine. These potent proteins require application directly at the site of repair via a delivery system. The choice of delivery system has a profound effect on the clinical outcome. In the past decade, researchers have focused on developing efficient delivery systems and advancing these factors from the bench to the clinic.
Li
R H
RH
Genetics Institute, 1 Burtt Road, 01810, Andover, MA, USA. rli@genetics.com
Wozney
J M
JM
D000818:Animals; D015519:Bone Density / Q000187:drug effects / Q000235:genetics; D019485:Bone Morphogenetic Proteins / Q000008:administration & dosage* / Q000235:genetics / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000639:trends*; D015316:Genetic Therapy / Q000639:trends; D006801:Humans
D019485:Bone Morphogenetic Proteins